Pharmaceutical Marketing Market by Type (Conference Marketing, PPC Advertising, Print Advertising), Business Model (B2B, B2C) - Global Forecast 2023-2030

Pharmaceutical Marketing Market by Type (Conference Marketing, PPC Advertising, Print Advertising), Business Model (B2B, B2C) - Global Forecast 2023-2030


The Pharmaceutical Marketing Market size was estimated at USD 36.94 billion in 2022 and expected to reach USD 41.41 billion in 2023, at a CAGR 12.58% to reach USD 95.36 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Pharmaceutical Marketing Market.
  • Based on Type, market is studied across Conference Marketing, PPC Advertising, Print Advertising, Social Media Campaigns, TV Commercials, and Website Pages & Campaigns. The Social Media Campaigns is projected to witness significant market share during forecast period.
  • Based on Business Model, market is studied across B2B and B2C. The B2B is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Pharmaceutical Marketing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Pharmaceutical Marketing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Pharmaceutical Marketing Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., AstraZeneca PLC, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Eli Lilly & Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Pharmaceutical Marketing Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Pharmaceutical Marketing Market?
  3. What is the competitive strategic window for identifying opportunities in the Pharmaceutical Marketing Market?
  4. What are the latest technology trends and regulatory frameworks in the Pharmaceutical Marketing Market?
  5. What is the market share of the leading vendors in the Pharmaceutical Marketing Market?
  6. Which modes and strategic moves are suitable for entering the Pharmaceutical Marketing Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharmaceutical Marketing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Proliferation of the pharmaceutical sector
5.1.1.2. Rise in pharmaceutical research and the need to increase product access
5.1.1.3. Need for leveraging pharmaceutical product positioning and pricing
5.1.2. Restraints
5.1.2.1. Substantial cost of pharmaceutical marketing
5.1.3. Opportunities
5.1.3.1. Integration of digital tools in pharmaceutical marketing
5.1.3.2. Shift towards a value-based and personalized approach
5.1.4. Challenges
5.1.4.1. Problems associated with misleading marketing and strict regulatory environment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Pharmaceutical Marketing Market, by Type
6.1. Introduction
6.2. Conference Marketing
6.3. PPC Advertising
6.4. Print Advertising
6.5. Social Media Campaigns
6.6. TV Commercials
6.7. Website Pages & Campaigns
7. Pharmaceutical Marketing Market, by Business Model
7.1. Introduction
7.2. B2B
7.3. B2C
8. Americas Pharmaceutical Marketing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Pharmaceutical Marketing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Pharmaceutical Marketing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Amgen Inc.
12.1.2. AstraZeneca PLC
12.1.3. Biogen Inc.
12.1.4. Boehringer Ingelheim International GmbH
12.1.5. Bristol Myers Squibb Company
12.1.6. Eli Lilly & Company
12.1.7. F. Hoffmann-La Roche AG
12.1.8. GlaxoSmithKline PLC
12.1.9. Merck & Co. Inc.
12.1.10. Novartis AG
12.1.11. Novo Nordisk A/S
12.1.12. Pfizer Inc.
12.1.13. Sanofi S.A.
12.1.14. Takeda Pharmaceutical Company Limited
12.1.15. Teva Pharmaceutical Industries Ltd.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings